| Bipolar Transurethral Enucleation Versus Resection in the Treatment of Benign Prostatic Hyperplasia: a Comparative Study (NCT06294366) | Menoufia University | 2022-06-12 |
| The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History (NCT05506735) | University of Baghdad | 2022-05-01 |
| Prostatic Hyperplasia Treatment and Cancer Prevention (NCT03064282) | Manchanda Medical Clinic | 2021-06-30 |
| The Clinical Efficacy of Rezūm Therapy Versus Bipolar Trans-urethral Resection of the Prostate for Treatment Benign Prostatic Hyperplasia (NCT06116370) | Ain Shams University | 2021-06-01 |
| SGLT Inhibitors Versus DDP4 Inhibitors and Prostate in Patient With Diabetes (NCT06148259) | Kasr El Aini Hospital | 2021-03-12 |
| Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia (NCT04588857) | Rigshospitalet, Denmark | 2021-03-01 |
| One-year Results After Single-center Water Vapor Thermal Therapy for Symptomatic Benign Prostatic Hyperplasia. (NCT06257654) | Hisar Intercontinental Hospital | 2021-01-01 |
| Efficacy of α-blocker or 5-ARI Withdrawal to Continued Combination Therapy on the Maintenance of LUTS in Men With BPH (NCT05023824) | Gangnam Severance Hospital | 2020-12-08 |
| Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA (NCT04760483) | Urological Research Network, LLC | 2020-11-20 |
| Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia (NCT04398966) | University of North Carolina, Chapel Hill | 2020-09-23 |
| Evaluation of the Effect of Garcinia in Combination With Chromium on the Clinical Outcomes of Patients With LUTS/BPH (NCT04590534) | Benha University | 2020-08-01 |
| Benign Prostatic Hyperplasia (BPH) Mobile Application Pilot Study (NCT03228485) | Société Internationale d'Urologie | 2019-04-04 |
| Benign Prostatic Hyperplasia and Glycosaminoglycan (NCT03955484) | Marmara University | 2019-04-01 |
| Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men (NCT04108871) | The University of Hong Kong | 2018-10-03 |
| Ejaculation Preserving Photoselective Vaporization Versus Plasma Kinetic Vaporization Versus Transurethral Resection Of The Prostate: A RCT (NCT03589196) | Mansoura University | 2018-03-10 |
| Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer (NCT03354416) | National Cancer Institute (NCI) | 2018-02-26 |
| HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia (NCT04561505) | Ain Shams University | 2018-02-01 |
| Evaluation of the Satisfaction of the Patients Operated for a Mild Hyperplasie of the Prostate by Laser in Ambulatory Surgery (NCT03474419) | Fondation Hôpital Saint-Joseph | 2017-11-24 |
| Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia (NCT03179228) | John D Louie | 2017-10-14 |
| The Influence of Benign Prostatic Hyperplasia on Bladder Function (NCT03098147) | Xiangfu Zhou | 2017-03-01 |
| Bipolar Needlescopic Enucleation Versus Vapoenucleation of BPH (NCT04331301) | Benha University | 2017-01-10 |
| Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years (NCT02757963) | GlaxoSmithKline | 2016-05-12 |
| Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms (NCT02252367) | University of Florence | 2015-12-01 |
| Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia (NCT02592473) | University of Virginia | 2015-11-01 |
| PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers (NCT02715401) | Hanmi Pharmaceutical Company Limited | 2015-10-01 |
| Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams (NCT02396420) | South Florida Medical Imaging, PA | 2015-09-24 |
| Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects (NCT02578953) | GlaxoSmithKline | 2015-09-09 |
| Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects (NCT02509104) | GlaxoSmithKline | 2015-07-30 |
| Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan (NCT02496442) | Flowmed | 2015-07-01 |
| Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers (NCT02712411) | Hanmi Pharmaceutical Company Limited | 2015-07-01 |
| HoLEP (50W) vs. HoLEP (100W) for Treatment of BPH (NCT02737241) | Mansoura University | 2015-06-01 |
| Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male. (NCT02417831) | Boehringer Ingelheim | 2015-04-30 |
| Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fed Male. (NCT02417844) | Boehringer Ingelheim | 2015-04-01 |
| Bipolar Plasmakinetic TURP Vs Monopolar TURP in the Treatment of Lower Urinary Tract Symptoms (NCT03936244) | Hospital Universitario de Fuenlabrada | 2014-12-05 |
| Digital Rectal Exam Proficiency Tool (NCT02278679) | University of Virginia | 2014-10-01 |
| Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia (NCT02947958) | Hospital de Clinicas de Porto Alegre | 2014-09-01 |
| Impact of Postoperative Pyuria on Treatment Outcomes After PVP (NCT02241902) | DongGuk University | 2014-08-01 |
| Predictors of de Novo Urge Urinary Incontinence After Photoselective Vaporization of the Prostate (NCT02243085) | DongGuk University | 2014-08-01 |
| Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States (NCT02184585) | GlaxoSmithKline | 2014-07-10 |
| Impact of Bladder Underactivity on Treatment Outcomes of Laser Prostatectomy (NCT02243540) | Seoul National University Hospital | 2014-04-01 |
| Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia (NCT02058368) | GlaxoSmithKline | 2014-02-10 |
| The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia (NCT02033798) | The Catholic University of Korea | 2014-02-01 |
| Storage Symptom After Laser Prostatectomy (NCT02073799) | Seoul National University Hospital | 2014-02-01 |
| Functional Changes of Urogenital System After Holmium Laser Prostatectomy (NCT02033785) | The Catholic University of Korea | 2014-02-01 |
| Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia (NCT03385161) | Cairo University | 2013-12-01 |
| Information Improvement for Surgical Patients Through Portable Video Media (NCT02846467) | Hospital Universitario Puerto Real | 2013-12-01 |
| This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples (NCT01957189) | GlaxoSmithKline | 2013-10-25 |
| Study of the Effect of Testosterone Treatment on Metabolic Parameters and Urinary Symptoms in Bariatric Patients (NCT02248467) | University of Florence | 2013-05-01 |
| Prospective Sexual Function Study for BPH Subjects (NCT01777269) | GlaxoSmithKline | 2013-02-18 |
| TRT on BPH Hypoganadal MetS Patients. Florence-PROTEST (NCT02366975) | University of Florence | 2012-11-01 |
| WEUSKOP5723: Prostate Cancer Study (NCT01767363) | GlaxoSmithKline | 2012-11-01 |
| Bioequivalence - Duodart Against Avodart & Omnic (NCT01657851) | GlaxoSmithKline | 2012-08-23 |
| Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (NCT01673490) | GlaxoSmithKline | 2012-06-29 |
| Rezum I Pilot Study for Benign Prostatic Hyperplasia (NCT02943070) | Boston Scientific Corporation | 2012-03-01 |
| A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia (NCT01495026) | GlaxoSmithKline | 2011-11-06 |
| Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (NCT01471678) | GlaxoSmithKline | 2011-06-30 |
| Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects (NCT01577693) | GlaxoSmithKline | 2011-05-12 |
| A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy (NCT01275521) | University Hospital, Bordeaux | 2011-01-10 |
| Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (NCT01294592) | GlaxoSmithKline | 2010-12-22 |
| Drug Use Investigation for AVOLVE(BPH) (NCT01376284) | GlaxoSmithKline | 2010-12-01 |
| The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction (NCT01482676) | Insel Gruppe AG, University Hospital Bern | 2010-10-01 |
| Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database (NCT01376258) | GlaxoSmithKline | 2010-10-01 |
| A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. (NCT01254071) | GlaxoSmithKline | 2010-09-10 |
| Evaluating the Impact of Early Versus Delayed 5 Alpha Reductase Inhibitor Treatment on the Risk of Emergent Surgery in Men With Benign Prostatic Hyperplasia (NCT01332487) | GlaxoSmithKline | 2010-08-01 |
| Establishing the Benefits of Adherence to Enlarged Prostate Treatment: A Validation Study Linking Adherence to Outcomes Using the Market Scan Database (NCT01381510) | GlaxoSmithKline | 2010-06-01 |
| Benign Prostatic Hypertrophy Treatment Patterns & Outcomes: Marketscan (NCT01323998) | GlaxoSmithKline | 2010-04-01 |
| Demonstrating the Clinical and Economic Benefit of 5 Alpha Reductase Inhibitor Adherence in Benign Prostatic Hyperplasia (NCT01334723) | GlaxoSmithKline | 2010-04-01 |
| SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fast Admin (NCT01262989) | GlaxoSmithKline | 2010-01-04 |
| SECOTEX® (Tamsulosin Hydrochloride) Bioequivalence Study Brazil - Fed Admin (NCT01330303) | GlaxoSmithKline | 2009-12-08 |
| Transient Urinary Incontinence After Holmium Laser Enucleation of the Prostate (HoLEP) (NCT01108367) | Seoul National University Hospital | 2009-11-01 |
| Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use (NCT01332435) | GlaxoSmithKline | 2009-11-01 |
| Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence (NCT01390870) | GlaxoSmithKline | 2009-05-01 |
| A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH) (NCT01003886) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-05-01 |
| MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use (NCT01050465) | University of Missouri-Columbia | 2009-05-01 |
| MEN STUDY (ESTUDIO MEN) Quality of Life in Patients With BPH and Nocturia Before and After Tamsulosin Ocas® Treatment (NCT00885027) | Boehringer Ingelheim | 2009-03-01 |
| Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment (NCT01386983) | GlaxoSmithKline | 2009-03-01 |
| A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia (NCT00793819) | Watson Pharmaceuticals | 2009-01-01 |
| Prostate Mechanical Imager (PMI) Clinical Bridging Study (NCT00822952) | Artann Laboratories | 2008-10-01 |
| A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 (NCT00814736) | Pfizer | 2008-08-01 |
| A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. (NCT00609596) | GlaxoSmithKline | 2008-02-26 |
| Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia (NCT00596011) | H. Lee Moffitt Cancer Center and Research Institute | 2007-11-14 |
| A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State (NCT00537654) | GlaxoSmithKline | 2007-10-18 |
| Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) (NCT00527605) | GlaxoSmithKline | 2007-10-01 |
| Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms (NCT00408954) | Pfizer | 2007-03-01 |
| A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (NCT00510406) | Astellas Pharma Inc | 2007-01-01 |
| Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia (NCT00399464) | Sanofi | 2006-11-01 |
| Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study (NCT00427882) | Handok Inc. | 2006-09-01 |
| ALF-STONE: Alfuzosin in Uretheric Stones (NCT00454402) | Sanofi | 2006-08-01 |
| Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia (NCT02245555) | Boehringer Ingelheim | 2006-04-01 |
| SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin (NCT00486785) | Sanofi | 2006-04-01 |
| Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS (NCT00517179) | Hospital Authority, Hong Kong | 2006-04-01 |
| Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects (NCT00368979) | GlaxoSmithKline | 2006-02-17 |
| The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients (NCT00497939) | Hospital Authority, Hong Kong | 2006-01-01 |
| ALF-ONE : ALFuzosin ONcE Daily (NCT00280605) | Sanofi | 2005-08-01 |
| Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) (NCT00116571) | QLT Inc. | 2005-05-01 |
| The Impact of Alna® Ocas® on Nocturia in Patients With Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH) (NCT02245542) | Boehringer Ingelheim | 2005-04-01 |
| Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia (NCT02245529) | Boehringer Ingelheim | 2005-03-01 |
| Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA) (NCT00169585) | GlaxoSmithKline | 2005-03-01 |
| AVODART(Dutasteride) Post-marketing Surveillance(PMS) (NCT01299571) | GlaxoSmithKline | 2004-12-01 |
| Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS (NCT00316732) | GlaxoSmithKline | 2004-10-25 |